Banco Bilbao Vizcaya Argentaria S.A. Buys 10,001 Shares of Colgate-Palmolive Company $CL

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Banco Bilbao Vizcaya Argentaria S.A. raised its holdings in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 5.1% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 207,083 shares of the company's stock after purchasing an additional 10,001 shares during the quarter. Banco Bilbao Vizcaya Argentaria S.A.'s holdings in Colgate-Palmolive were worth $19,407,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently bought and sold shares of CL. Van Lanschot Kempen Investment Management N.V. lifted its position in shares of Colgate-Palmolive by 7.9% during the first quarter. Van Lanschot Kempen Investment Management N.V. now owns 139,206 shares of the company's stock worth $13,044,000 after acquiring an additional 10,240 shares in the last quarter. Legacy Financial Advisors Inc. increased its position in shares of Colgate-Palmolive by 7.3% during the first quarter. Legacy Financial Advisors Inc. now owns 2,626 shares of the company's stock valued at $246,000 after buying an additional 179 shares during the period. Hsbc Holdings PLC lifted its holdings in shares of Colgate-Palmolive by 7.7% in the first quarter. Hsbc Holdings PLC now owns 2,975,239 shares of the company's stock worth $278,621,000 after buying an additional 212,670 shares in the last quarter. CWS Financial Advisors LLC increased its holdings in Colgate-Palmolive by 9.5% during the 1st quarter. CWS Financial Advisors LLC now owns 4,589 shares of the company's stock worth $430,000 after acquiring an additional 400 shares during the period. Finally, RWA Wealth Partners LLC boosted its holdings in Colgate-Palmolive by 33.9% in the 1st quarter. RWA Wealth Partners LLC now owns 246,846 shares of the company's stock valued at $23,129,000 after purchasing an additional 62,523 shares during the period. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Trading Up 0.2%

Colgate-Palmolive stock traded up $0.2120 during mid-day trading on Thursday, hitting $86.2620. The company's stock had a trading volume of 4,880,464 shares, compared to its average volume of 4,935,793. The business has a 50 day moving average price of $87.69 and a 200-day moving average price of $89.91. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57. Colgate-Palmolive Company has a 12 month low of $82.40 and a 12 month high of $109.30. The stock has a market cap of $69.72 billion, a price-to-earnings ratio of 24.23, a price-to-earnings-growth ratio of 4.47 and a beta of 0.35.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings data on Friday, August 1st. The company reported $0.92 EPS for the quarter, topping the consensus estimate of $0.89 by $0.03. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The firm had revenue of $5.11 billion for the quarter, compared to the consensus estimate of $5.03 billion. During the same quarter in the previous year, the business earned $0.91 earnings per share. The company's quarterly revenue was up 1.0% on a year-over-year basis. As a group, analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were issued a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date was Friday, July 18th. Colgate-Palmolive's payout ratio is currently 58.43%.

Analysts Set New Price Targets

CL has been the topic of a number of recent analyst reports. Wall Street Zen downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating in a research report on Wednesday, May 7th. Citigroup decreased their price objective on shares of Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating on the stock in a research report on Monday, August 4th. Morgan Stanley dropped their target price on shares of Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating for the company in a research report on Monday, August 4th. UBS Group cut their price target on shares of Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating for the company in a research note on Thursday, July 17th. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating on the stock in a research report on Monday, August 4th. Seven equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $98.92.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.